|
Volumn 14, Issue 12, 2000, Pages 671-
|
Entry inhibitor combination shows promise.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CD4 IMMUNOGLOBULIN;
CD4 IMMUNOGLOBULIN G2;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;
MONOCLONAL ANTIBODY;
PEPTIDE FRAGMENT;
PRO 140;
ARTICLE;
DRUG COMBINATION;
DRUG POTENTIATION;
DRUG SCREENING;
HUMAN;
TREATMENT OUTCOME;
ANTI-HIV AGENTS;
ANTIBODIES, MONOCLONAL;
CD4 IMMUNOADHESINS;
DRUG EVALUATION, PRECLINICAL;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HIV ANTIBODIES;
HIV ENVELOPE PROTEIN GP41;
HUMANS;
PEPTIDE FRAGMENTS;
TREATMENT OUTCOME;
|
EID: 0034573617
PISSN: 10872914
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|